Phase I trial of PBI 4050 in healthy volunteers (first-in-man trial)

Trial Profile

Phase I trial of PBI 4050 in healthy volunteers (first-in-man trial)

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2015

At a glance

  • Drugs PBI 4050 (Primary)
  • Indications Diabetic nephropathies; Renal fibrosis
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors ProMetic Life Sciences
  • Most Recent Events

    • 09 Nov 2015 Results from this phase I study have been presented at the American Society of Nephrology (ASN) annual meeting.
    • 11 Sep 2014 New trial record
    • 03 Sep 2014 Results published in the Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top